Abiopharma

🔍 Synge James (Director)

Company: Life360, Inc. (LIF)

Report Date: 2026-05-29

Detailed Transactions and Holdings:

• Acquired 4,600 shares of Common stock (Direct)
  Date: 2026-05-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 191,021.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2026, subject to the Reporting Person's continuous service through each vest date.
• F2: Includes 5,303 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
• F3: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.